Edition:
United Kingdom

People: Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

0.57USD
23 Aug 2019
Change (% chg)

$-0.04 (-5.74%)
Prev Close
$0.61
Open
$0.61
Day's High
$0.62
Day's Low
$0.57
Volume
11,415
Avg. Vol
33,337
52-wk High
$1.32
52-wk Low
$0.55

Korner, Assaf 

Mr. Assaf Korner is appointed as Chief Financial Officer of the company effective January 8, 2018. He has over 15 years of financial experience in medical device and consumer product companies. Prior to joining Bellerophon, Mr. Korner served as the Chief Financial Officer of L&R Distributors, a national consumer product distributor, since 2016. Prior to that, Mr. Korner served as the Chief Financial Officer of Iluminage Beauty, a Joint Venture between Unilever and Syneron Medical, from 2011 through 2016. Prior to Iluminage, Mr. Korner held several senior finance roles in Syneron Medical from 2005 through 2011. Prior to Syneron Medical, Mr. Korner served as a Senior Auditor at KPMG. Mr. Korner holds an MBA from Tel-Aviv University, a Bachelor’s degree in Accounting and Economics from Haifa University and is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --